These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15124213)

  • 1. Evaluation of the relationship of the molecular aggregation state of amphotericin B in medium to its genotoxic potential.
    Egito LC; de Medeiros SR; Medeiros MG; Price JC; Egito ES
    J Pharm Sci; 2004 Jun; 93(6):1557-65. PubMed ID: 15124213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in Fungizone toxicity induced by the use of Lipofundin as a dilutent: an in vitro study.
    de Araújo IB; Damasceno BP; de Medeiros TM; Soares LA; do Egito ES
    Curr Drug Deliv; 2005 Apr; 2(2):199-205. PubMed ID: 16305421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aggregation state on the toxicity of different amphotericin B preparations.
    Espada R; Valdespina S; Alfonso C; Rivas G; Ballesteros MP; Torrado JJ
    Int J Pharm; 2008 Sep; 361(1-2):64-9. PubMed ID: 18599228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amphotericin B/emulsion admixture interactions: an approach concerning the reduction of amphotericin B toxicity.
    Egito ES; Araújo IB; Damasceno BP; Price JC
    J Pharm Sci; 2002 Nov; 91(11):2354-66. PubMed ID: 12379920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS).
    Fukui H; Koike T; Saheki A; Sonoke S; Tomii Y; Seki J
    Int J Pharm; 2003 Sep; 263(1-2):51-60. PubMed ID: 12954180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.
    Gangadhar KN; Adhikari K; Srichana T
    Int J Pharm; 2014 Aug; 471(1-2):430-8. PubMed ID: 24907597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the toxicity of a new lipid complex formulation of amphotericin B.
    Larabi M; Pages N; Pons F; Appel M; Gulik A; Schlatter J; Bouvet S; Barratt G
    J Antimicrob Chemother; 2004 Jan; 53(1):81-8. PubMed ID: 14657087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentration dependent dual effect of the monolauryl ester of sucrose on the antifungal activity and absorption spectra of amphotericin B (Fungizone).
    Brajtburg J; Gruda I; Daigle I; Medoff G
    Biochim Biophys Acta; 1989 Nov; 985(3):307-12. PubMed ID: 2679886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular dichroism study of interactions of Fungizone or AmBisome forms of amphotericin B with human low density lipoproteins.
    Barwicz J; Beauregard M; Tancrède P
    Biopolymers; 2002; 67(1):49-55. PubMed ID: 11842413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low nephrotoxicity of an effective amphotericin B formulation with cationic bilayer fragments.
    Lincopan N; Mamizuka EM; Carmona-Ribeiro AM
    J Antimicrob Chemother; 2005 May; 55(5):727-34. PubMed ID: 15761070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes.
    Legrand P; Romero EA; Cohen BE; Bolard J
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2518-22. PubMed ID: 1489196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the leishmanicidal activity of fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles.
    Ramos H; Brajtburg J; Marquez V; Cohen BE
    Drugs Exp Clin Res; 1995; 21(6):211-6. PubMed ID: 8907695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative pharmacokinetics and safety of a novel lyophilized amphotericin B lecithin-based oil-water microemulsion and amphotericin B deoxycholate in animal models.
    Brime B; Frutos P; Bringas P; Nieto A; Ballesteros MP; Frutos G
    J Antimicrob Chemother; 2003 Jul; 52(1):103-9. PubMed ID: 12805269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disaggregation of amphotericin B by sodium deoxycholate micellar aggregates.
    Selvam S; Mishra AK
    J Photochem Photobiol B; 2008 Nov; 93(2):66-70. PubMed ID: 18725181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of amphotericin b derivatives on Leishmania and immune functions.
    Ehrenfreund-Kleinman T; Domb AJ; Jaffe CL; Nasereddin A; Leshem B; Golenser J
    J Parasitol; 2005 Feb; 91(1):158-63. PubMed ID: 15856892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
    Jain S; Valvi PU; Swarnakar NK; Thanki K
    Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal amphotericin B and amphotericin B-deoxycholate show different immunoregulatory effects on human peripheral blood mononuclear cells.
    Reyes E; Cardona J; Prieto A; Bernstein ED; Rodríguez-Zapata M; Pontes MJ; Alvarez-Mon M
    J Infect Dis; 2000 Jun; 181(6):2003-10. PubMed ID: 10837182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicochemical characterization of molecular assemblies of miltefosine and amphotericin B.
    Ménez C; Legrand P; Rosilio V; Lesieur S; Barratt G
    Mol Pharm; 2007; 4(2):281-8. PubMed ID: 17397240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation.
    Gupta PK; Jaiswal AK; Kumar V; Verma A; Dwivedi P; Dube A; Mishra PR
    Mol Pharm; 2014 Mar; 11(3):951-63. PubMed ID: 24495144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of an effective amphotericin B formulation at high cationic lipid to drug molar ratio.
    Lincopan N; Borelli P; Fock R; Mamizuka EM; Carmona-Ribeiro AM
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):175-83. PubMed ID: 16982179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.